Clinical trial NCT02573714 - References

Sickle Cell Disease — Sub-dissociative Intranasal Ketamine for Pediatric Sickle Cell Pain Crises

Citation(s)

•   Alli NA, Patel M, Alli HD, Bassa F, Coetzee MJ, Davidson A, Essop MR, Lakha A, Louw VJ, Novitzky N, Philip V, Poole JE, Wainwright RD
  Recommendations for the management of sickle cell disease in South Africa. S Afr Med J. 2014 Nov;104(11):743-51. Review.
•   Aloni MN, Nkee L
  Challenge of managing sickle cell disease in a pediatric population living in kinshasa, democratic republic of congo: a sickle cell center experience. Hemoglobin. 2014;38(3):196-200. doi: 10.3109/03630269.2014.896810. Epub 2014 Mar 26.
•   Ambe JP, Mava Y, Chama R, Farouq G, Machoko Y
  Clinical features of sickle cell anaemia in northern nigerian children. West Afr J Med. 2012 Apr-Jun;31(2):81-5.
•   American Pain Society (1999a) Guideline for the Management of Acute and Chronic Pain in Sickle Cell Disease
  American Pain Society, Glenview, IL.
•   Andolfatto G, Willman E, Joo D, Miller P, Wong WB, Koehn M, Dobson R, Angus E, Moadebi S
  Intranasal ketamine for analgesia in the emergency department: a prospective observational series. Acad Emerg Med. 2013 Oct;20(10):1050-4. doi: 10.1111/acem.12229.
•   Arya R, Gulati S, Kabra M, Sahu JK, Kalra V
  Intranasal versus intravenous lorazepam for control of acute seizures in children: a randomized open-label study. Epilepsia. 2011 Apr;52(4):788-93. doi: 10.1111/j.1528-1167.2010.02949.x. Epub 2011 Jan 28.
•   Borland M, Jacobs I, King B, O'Brien D
  A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department. Ann Emerg Med. 2007 Mar;49(3):335-40. Epub 2006 Oct 25.
•   Chien YW, Su KSE, Chang SF, Chapter 1: Anatomy and Physiology of the Nose
  Nasal Systemic Drug Delivery, 1989. Dekker, New York: p. 1-26.
•   Diallo D, Tchernia G
  Sickle cell disease in Africa. Curr Opin Hematol. 2002 Mar;9(2):111-6. Review.
•   Donnelly RF
  Stability of diluted ketamine packaged in glass vials. Can J Hosp Pharm. 2013 May;66(3):198.
•   Fu ES, Miguel R, Scharf JE
  Preemptive ketamine decreases postoperative narcotic requirements in patients undergoing abdominal surgery. Anesth Analg. 1997 May;84(5):1086-90.
•   GBD 2013 Mortality and Causes of Death Collaborators
  Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015 Jan 10;385(9963):117-71. doi: 10.1016/S0140-6736(14)61682-2. Epub 2014 Dec 18.
•   Gill FM, Sleeper LA, Weiner SJ, Brown AK, Bellevue R, Grover R, Pegelow CH, Vichinsky E
  Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease. Blood. 1995 Jul 15;86(2):776-83. Review.
•   Govoni MM
  Mandatory education and credentialing for dental assistants: is it the answer to the manpower crisis? Dent Assist. 1990 Jul-Aug;59(4):9-12.
•   Graudins A, Meek R, Egerton-Warburton D, Oakley E, Seith R
  The PICHFORK (Pain in Children Fentanyl or Ketamine) trial: a randomized controlled trial comparing intranasal ketamine and fentanyl for the relief of moderate to severe pain in children with limb injuries. Ann Emerg Med. 2015 Mar;65(3):248-254.e1. doi: 10.1016/j.annemergmed.2014.09.024. Epub 2014 Nov 18.
•   Green SM, Clem KJ, Rothrock SG
  Ketamine safety profile in the developing world: survey of practitioners. Acad Emerg Med. 1996 Jun;3(6):598-604.
•   Green SM, Roback MG, Krauss B, Brown L, McGlone RG, Agrawal D, McKee M, Weiss M, Pitetti RD, Hostetler MA, Wathen JE, Treston G, Garcia Pena BM, Gerber AC, Losek JD; Emergency Department Ketamine Meta-Analysis Study Group
  Predictors of airway and respiratory adverse events with ketamine sedation in the emergency department: an individual-patient data meta-analysis of 8,282 children. Ann Emerg Med. 2009 Aug;54(2):158-68.e1-4. doi: 10.1016/j.annemergmed.2008.12.011. Epub 2009 Feb 7.
•   Herd DW, Anderson BJ, Keene NA, Holford NH
  Investigating the pharmacodynamics of ketamine in children. Paediatr Anaesth. 2008 Jan;18(1):36-42.
•   Johansson J, Sjöberg J, Nordgren M, Sandström E, Sjöberg F, Zetterström H
  Prehospital analgesia using nasal administration of S-ketamine--a case series. Scand J Trauma Resusc Emerg Med. 2013 May 14;21:38. doi: 10.1186/1757-7241-21-38.
•   Kohrs R, Durieux ME
  Ketamine: teaching an old drug new tricks. Anesth Analg. 1998 Nov;87(5):1186-93. Review.
•   Makani J, Ofori-Acquah SF, Nnodu O, Wonkam A, Ohene-Frempong K
  Sickle cell disease: new opportunities and challenges in Africa. ScientificWorldJournal. 2013;2013:193252. doi: 10.1155/2013/193252. Epub 2013 Sep 19. Review.
•   Malinovsky JM, Servin F, Cozian A, Lepage JY, Pinaud M
  Ketamine and norketamine plasma concentrations after i.v., nasal and rectal administration in children. Br J Anaesth. 1996 Aug;77(2):203-7.
•   Nesher N, Ekstein MP, Paz Y, Marouani N, Chazan S, Weinbroum AA
  Morphine with adjuvant ketamine vs higher dose of morphine alone for immediate postthoracotomy analgesia. Chest. 2009 Jul;136(1):245-252. doi: 10.1378/chest.08-0246. Epub 2008 Aug 27.
•   Nielsen BN, Friis SM, Rømsing J, Schmiegelow K, Anderson BJ, Ferreirós N, Labocha S, Henneberg SW
  Intranasal sufentanil/ketamine analgesia in children. Paediatr Anaesth. 2014 Feb;24(2):170-80. doi: 10.1111/pan.12268. Epub 2013 Oct 1.
•   Ogun GO, Ebili H, Kotila TR
  Autopsy findings and pattern of mortality in Nigerian sickle cell disease patients. Pan Afr Med J. 2014 May 8;18:30. doi: 10.11604/pamj.2014.18.30.4043. eCollection 2014.
•   Olabode JO, Shokunbi WA
  Types of crises in sickle cell disease patients presenting at the haematology day care unit (HDCU), University College Hospital (UCH), Ibadan. West Afr J Med. 2006 Oct-Dec;25(4):284-8.
•   Palermo TM, Riley CA, Mitchell BA
  Daily functioning and quality of life in children with sickle cell disease pain: relationship with family and neighborhood socioeconomic distress. J Pain. 2008 Sep;9(9):833-40. doi: 10.1016/j.jpain.2008.04.002. Epub 2008 Jun 12.
•   Pandey RK, Bahetwar SK, Saksena AK, Chandra G
  A comparative evaluation of drops versus atomized administration of intranasal ketamine for the procedural sedation of young uncooperative pediatric dental patients: a prospective crossover trial. J Clin Pediatr Dent. 2011 Fall;36(1):79-84.
•   PedsQL Sickle Cell Disease Module, Version 3
  0. 1998 JW Varni, Ph.D. (http://www.proqolid.org/instruments/pediatric_quality_of_life_inventory_sickle_cell_disease_module_pedsql_sickle_cell_disease_module)
•   Piel FB, Hay SI, Gupta S, Weatherall DJ, Williams TN
  Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions. PLoS Med. 2013;10(7):e1001484. doi: 10.1371/journal.pmed.1001484. Epub 2013 Jul 16.
•   Pires A, Fortuna A, Alves G, Falcão A
  Intranasal drug delivery: how, why and what for? J Pharm Pharm Sci. 2009;12(3):288-311. Review.
•   Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, Kinney TR
  Pain in sickle cell disease. Rates and risk factors. N Engl J Med. 1991 Jul 4;325(1):11-6.
•   Quinn CT, Shull EP, Ahmad N, Lee NJ, Rogers ZR, Buchanan GR
  Prognostic significance of early vaso-occlusive complications in children with sickle cell anemia. Blood. 2007 Jan 1;109(1):40-5. Epub 2006 Aug 29.
•   Reich DL, Silvay G
  Ketamine: an update on the first twenty-five years of clinical experience. Can J Anaesth. 1989 Mar;36(2):186-97. Review.
•   Smith DC, Mader TJ, Smithline HA
  Low dose intravenous ketamine as an analgesic: a pilot study using an experimental model of acute pain. Am J Emerg Med. 2001 Oct;19(6):531-2.
•   Tayebati SK, Nwankwo IE, Amenta F
  Intranasal drug delivery to the central nervous system: present status and future outlook. Curr Pharm Des. 2013;19(3):510-26. Review.
•   Tsze DS, Steele DW, Machan JT, Akhlaghi F, Linakis JG
  Intranasal ketamine for procedural sedation in pediatric laceration repair: a preliminary report. Pediatr Emerg Care. 2012 Aug;28(8):767-70.
•   Walker SE, Law S, DeAngelis C
  Stability and compatibility of hydromorphone and ketamine in normal saline. Can J Hosp Pharm. 2001;54(3):191-199.
•   White JM, Ryan CF
  Pharmacological properties of ketamine. Drug Alcohol Rev. 1996 Jun;15(2):145-55.
•   Who
  int,. "WHO | WHO Model Lists Of Essential Medicines." N.p., 2015. Web. 20 July 2015.
•   Wolfe TR, Braude DA
  Intranasal medication delivery for children: a brief review and update. Pediatrics. 2010 Sep;126(3):532-7. doi: 10.1542/peds.2010-0616. Epub 2010 Aug 9. Review.
•   World Health Organisation, "Sickle cell anaemia
  Agenda item 11.4," in 59th World Health Assembly, 27 May 2006, World Health Organisation, Geneva, Switzerland, 2006.
•   Yanagihara Y, Ohtani M, Kariya S, Uchino K, Hiraishi T, Ashizawa N, Aoyama T, Yamamura Y, Yamada Y, Iga T
  Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers. Biopharm Drug Dispos. 2003 Jan;24(1):37-43.
•   Yeaman F, Oakley E, Meek R, Graudins A
  Sub-dissociative dose intranasal ketamine for limb injury pain in children in the emergency department: a pilot study. Emerg Med Australas. 2013 Apr;25(2):161-7. doi: 10.1111/1742-6723.12059. Epub 2013 Mar 20.

Comparison of Sub-dissociative Intranasal Ketamine Plus Standard Pain Therapy Versus Standard Pain Therapy in the Treatment of Pediatric Sickle Cell Disease Vasoocclusive Crises in Resource-limited Settings: a Multi-centered, Randomized, Controlled Trial

Details for clinical trial NCT02573714